The role of bile acid sequestrants in the management of type 2 diabetes mellitus.
Ganda
Om P
OP
Lipid Clinic, Joslin Diabetes Center and Department of Medicine, Harvard Medical School , Boston, Massachusetts 02115, USA. om.ganda@joslin.harvard.edu
D000328:Adult; D000499:Allylamine / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000378:metabolism / Q000627:therapeutic use*; D001647:Bile Acids and Salts / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000209:etiology; D002986:Clinical Trials as Topic; D000069472:Colesevelam Hydrochloride; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans
D000924:Anticholesteremic Agents; D001647:Bile Acids and Salts; D000499:Allylamine; D000069472:Colesevelam Hydrochloride